Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

661 articles

Showing 1–1 of 1 articles · Keyword: IgA Clear keyword

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V2026ResearchDrug Delivery

1. Lipid nanoparticles adjuvanted with poly(I:C) enhance respiratory mucosal immunity induced by a protein subunit vaccine

Da Costa Rodrigues T, Kola Ns, Patel D, Ibrahim A, Ma'aruf Sy, Haddadi A, Et Al.

Subunit vaccines are typically given through injections, which limits mucosal immunity. Most adjuvants do not stimulate mucosal responses but using lipid nanoparticles (LNPs) encapsulating polyinosinic-polycytidylic acid (poly(I:C)), a toll-like receptor 3 agonist, could enhance the immune response in the lungs. We…

Read the article
Articles | Brilliant Blue Biosciences